25 results
8-K
EX-99.2
ACUR
Acura Pharmaceuticals, Inc
27 Dec 22
To License, Development and Commercialization Agreement
4:56pm
at 2604 River Green Circle, Louisville, Kentucky 40206, or its assigns (the “Noteholder”), the aggregate principal sum of TWO MILLION THREE HUNDRED
8-K
EX-99.1
ACUR
Acura Pharmaceuticals, Inc
17 Oct 22
Entry into a Material Definitive Agreement
9:00am
to the order of John Schutte, having an office at c/o MainPointe Pharmaceuticals, LLC, 2604 River Green Circle, Louisville, KY 40206, or his assigns
8-K
EX-99.1
ACUR
Acura Pharmaceuticals, Inc
26 Sep 22
Entry into a Material Definitive Agreement
4:37pm
to the order of John Schutte, having an office at c/o MainPointe Pharmaceuticals, LLC, 2604 River Green Circle, Louisville, KY 40206, or his assigns
8-K
EX-99.1
pddcbd94nl 2w
26 Aug 22
Entry into a Material Definitive Agreement
12:21pm
8-K
EX-99.1
oa8 utgdshcrld8wt
19 Jul 22
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-99.1
4h4cc98 4grzbsm2luqc
11 Jul 22
Entry into a Material Definitive Agreement
1:40pm
8-K
EX-99.1
vd617elp 208
13 Jun 22
Entry into a Material Definitive Agreement
9:21am
8-K
EX-99.1
o7o5qwf7
23 May 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
12zkn835g mrj
2 May 22
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-99.1
q2n54ujnjpmj
4 Apr 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
hyzl8je5h 36jyknvc
1 Feb 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
4j5 q12u81w1w
4 Jan 22
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-99.1
ybafmuq1igezrn
28 Dec 21
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
786kr1121w py72mp
28 Sep 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
y2hh9ku9l
3 Mar 09
Other Events
12:00am
8-K
EX-99.1
8i9f5bvzx
2 Jan 09
Other Events
12:00am
8-K
EX-99.1
hsxq0r1wknz0jdpt0xbg
24 Dec 08
Other Events
12:00am
8-K
EX-99.1
9xrmu3ro72ou
14 Oct 08
Other Events
12:00am